ARTICLE | Finance
Hidden in the rough
Biotech winners, losers in 2Q18
June 30, 2018 3:05 AM UTC
Judicious stock picking was especially important in the second quarter, as 57% of global biotech stocks saw their equity values decline.
Volatility continued to roil global markets during the period and additional uncertainty looms with the U.S. mid-term elections on Nov. 6 expected to come into focus after the annual summer slowdown...